NasdaqGM - Nasdaq Real Time Price USD
Actuate Therapeutics, Inc. Common stock (ACTU)
9.65
+0.01
+(0.10%)
At close: May 14 at 4:00:01 PM EDT
8.90
-0.75
(-7.77%)
Pre-Market: 4:05:17 AM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BIOS EQUITY COF, LP Beneficial Owner of more than 10% of a Class of Security | Purchase | Aug 14, 2024 | -- |
| THOMSON TODD S. Director and Beneficial Owner of more than 10% of a Class of Security | Sale | Aug 14, 2024 | -- |
Related Tickers
RNTX Rein Therapeutics Inc.
2.2500
+14.80%
CUE Cue Biopharma, Inc.
0.7451
-2.97%
COYA Coya Therapeutics, Inc.
5.69
-1.22%
RNXT RenovoRx, Inc.
1.0500
+1.94%
DMAC DiaMedica Therapeutics Inc.
4.0000
+0.50%
CGTX Cognition Therapeutics, Inc.
0.3335
+3.83%
TNGX Tango Therapeutics, Inc.
1.2850
-8.21%
APS.TO Aptose Biosciences Inc.
2.3500
-7.48%
AAPG Ascentage Pharma Group Internat
23.40
-3.98%
VYNE VYNE Therapeutics Inc.
1.2600
-3.82%